農場動物疼痛緩解和預防市場 - 全球行業規模、佔有率、趨勢、機會和預測，按動物類型、產品類型、給藥途徑、最終用戶、地區和競爭細分，2020-2030F

2024 年全球農場動物疼痛緩解和預防市場價值為 563.2 億美元，預計到 2030 年將達到 970.1 億美元，複合年成長率為 9.46%。隨著全球畜牧業在動物治療方面面臨更嚴格的審查，人們更加重視改善動物的舒適度和減少疼痛，特別是在生產和醫療保健環境中。消費者對虐待動物的擔憂日益增加，特別是在已開發市場，促使他們需要緩解疼痛和預防解決方案。政府制定的促進更好治療和福利標準的法規進一步支持了這一趨勢，鼓勵牲畜所有者和農民採取更人道的做法，包括對農場動物進行疼痛管理。

市場概況
預測期	2026-2030
2024 年市場規模	563.2 億美元
2030 年市場規模	970.1 億美元
2025-2030 年複合年成長率	9.46%
成長最快的領域	局部麻醉藥
最大的市場	北美洲

獸醫技術的進步促進了農場動物止痛市場的擴大。非類固醇抗發炎藥（NSAID）和鴉片類藥物替代品等創新疼痛管理產品的開發提高了治療效果。致力於提高這些產品的功效和安全性的研究推動了市場的發展，並針對不同動物物種的需求推出了更專業的配方。人們越來越認知到疼痛是農場動物的一個重要福利問題，這導致在手術期間、受傷後或慢性病期間擴大採用疼痛緩解療法。畜牧業轉向預防措施是市場的​​主要驅動力。

儘管取得了這樣的成長，但市場仍面臨一些可能阻礙其進一步擴張的挑戰。先進的疼痛緩解治療的高成本仍然是一個重大障礙，特別是對於可能沒有財力實施這些解決方案的小規模和新興農民。此外，人們擔心一些農民，特別是發展中地區的農民缺乏對預防疼痛重要性的認知和教育。獸醫護理的可用性不一致以及不同物種的治療方案的複雜性也可能對市場造成障礙。圍繞新型疼痛管理產品的核准的監管挑戰進一步使市場格局複雜化，必須滿足嚴格的安全性和有效性指導原則才能廣泛採用。

主要市場促進因素

對優質動物性產品的需求不斷成長

獸藥領域的進展

畜牧養殖業成長

主要市場挑戰

止痛產品價格高昂

缺乏專業獸醫護理

主要市場趨勢

天然和有機止痛產品需求不斷成長

擴大鎮痛劑和麻醉劑的使用

分段洞察

動物類型洞察

最終用戶洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球農場動物疼痛緩解與預防市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依動物類型（牛、豬、家禽、馬、其他）
  • 依產品類型（非類固醇抗發炎藥、鴉片類藥物、麻醉藥、α-2 激動劑、皮質類固醇、局部麻醉藥、其他）
  • 依給藥途徑（口服、注射、外用、其他）
  • 按最終使用者（畜牧農民、獸醫診所及醫院、研究機構、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第 6 章：北美農場動物疼痛緩解與預防市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 墨西哥
  • 加拿大

第 7 章：歐洲農場動物疼痛緩解與預防市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 西班牙

第 8 章：亞太地區農場動物疼痛緩解與預防市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 印度
  • 韓國
  • 日本
  • 澳洲

第 9 章：南美農場動物疼痛緩解與預防市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲農場動物疼痛緩解和預防市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如果有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Bayer AG
• Neogen Corporation
• Merck & Co., Inc.
• Ceva Sante Animale SA
• Virbac SA
• Vetoquinol SA
• Norbrook Laboratories Ltd.

第 15 章：策略建議

第16章 關於出版商,免責事項

Global Farm Animal Pain Relief and Prevention Market was valued at USD 56.32 Billion in 2024 and is expected to reach USD 97.01 Billion in the forecast period with a CAGR of 9.46% through 2030. The Global Farm Animal Pain Relief and Prevention Market is experiencing significant growth driven by the increasing awareness regarding animal welfare and rising demand for sustainable farming practices. As the global livestock industry faces greater scrutiny over animal treatment, there is a stronger emphasis on improving animal comfort and reducing pain, especially in production and healthcare settings. Increasing consumer concerns over animal cruelty, particularly in developed markets, is prompting the need for pain relief and prevention solutions. Government regulations promoting better treatment and welfare standards further support this trend, encouraging livestock owners and farmers to adopt more humane practices, including pain management for farm animals.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 56.32 Billion
Market Size 2030	USD 97.01 Billion
CAGR 2025-2030	9.46%
Fastest Growing Segment	Local Anesthetics
Largest Market	North America

Technological advancements in veterinary medicine have contributed to the expansion of the farm animal pain relief market. The development of innovative pain management products, such as non-steroidal anti-inflammatory drugs (NSAIDs) and opioid alternatives, has enhanced the effectiveness of treatments. Research focused on improving the efficacy and safety of these products has driven the market forward, with more specialized formulations tailored to the needs of different animal species. The growing recognition of pain as a significant welfare issue in farm animals has led to increased adoption of pain relief therapies during surgery, after injuries, or for chronic conditions. This shift toward preventive measures in the livestock sector is a key market driver.

Despite this growth, the market faces several challenges that could impede its further expansion. High costs of advanced pain relief treatments remain a significant barrier, particularly for small-scale and emerging farmers who may not have the financial resources to implement these solutions. Additionally, there are concerns over the lack of awareness and education regarding the importance of pain prevention among some farmers, especially in developing regions. The inconsistent availability of veterinary care and the complexity of treatment protocols for different species can also pose hurdles in the market. Regulatory challenges surrounding the approval of new pain management products further complicate the market landscape, with stringent guidelines on safety and efficacy that must be met for widespread adoption.

Key Market Drivers

Growing Demand for High-Quality Animal Products

The growing demand for high-quality animal products is a significant driver for the Global Farm Animal Pain Relief and Prevention Market. As consumer preferences shift towards more humane, ethically produced meat and dairy products, there is an increased focus on animal welfare. Farms are under greater scrutiny to ensure their animals are treated with care and respect throughout their lifecycle, including during periods of pain or distress. Pain management, including the use of effective pain relief and prevention strategies, is becoming a critical aspect of maintaining high standards of animal welfare.

Consumers are more aware of the conditions under which their food is produced, and this has led to a demand for products that are ethically sourced, with minimal stress or discomfort to the animals. This shift is influencing farmers and livestock producers to adopt pain relief measures to prevent unnecessary suffering, especially in animals undergoing routine medical procedures such as vaccinations, castrations, and dehorning. The use of pain relief products not only aligns with animal welfare standards but also improves productivity by reducing the stress levels in animals, leading to better growth, feed conversion, and overall health.As the trend for premium, ethically produced animal products rises, governments and organizations are instituting more rigorous regulations surrounding animal welfare. This is pushing livestock producers to adopt pain relief solutions to comply with emerging standards and enhance the quality of their products. In this way, the growing demand for high-quality animal products serves as a key driver for the expansion of the farm animal pain relief and prevention market, ensuring that animal welfare and product quality go hand in hand.

According to the Food and Agriculture Organization (FAO), global meat consumption is projected to rise by 2% on a per capita basis by 2032, driven by increasing consumer sensitivity to animal welfare, environmental, and health concerns. This trend underscores the importance of adopting pain relief and prevention measures to meet consumer expectations for ethically produced animal products.

In the United States, the Department of Agriculture (USDA) has recognized the importance of organic and ethically produced products, with certified organic U.S. land increasing from 1.8 million acres in 2000 to 4.9 million acres in 2021. This growth reflects a significant shift in consumer demand towards products that adhere to higher animal welfare standards, further driving the need for effective pain management solutions in the livestock industry.

Advancements in Veterinary Pharmaceuticals

Advancements in veterinary pharmaceuticals play a significant role in driving the growth of the Global Farm Animal Pain Relief and Prevention Market. As livestock farming continues to evolve, there has been an increased focus on developing more effective and safer pain relief medications for farm animals. These advancements include the introduction of novel drug formulations and new classes of pain management drugs designed to target specific pain pathways more precisely. Veterinary pharmaceutical companies are increasingly investing in research and development to create drugs that not only alleviate pain but also minimize side effects and improve the overall welfare of farm animals.

For instance, innovations in injectable analgesics and non-invasive pain relief options are gaining traction. These pharmaceutical advancements are being driven by the growing awareness of animal welfare and the need for effective pain management during common agricultural procedures like castration, dehorning, and after surgeries. The demand for drugs that offer prolonged pain relief with fewer doses is also pushing forward the development of sustained-release formulations.

Moreover, the regulatory landscape has been evolving to encourage the development and approval of new veterinary pain management drugs, especially in regions with stringent regulations for animal health. As farmers and veterinarians seek to improve productivity by ensuring their livestock remains healthy and stress-free, advancements in pain relief therapies become essential. These innovations not only provide better outcomes for the animals but also help mitigate potential losses due to animal suffering and prevent longer-term health complications. The ongoing improvement in veterinary pharmaceuticals is likely to continue driving the market for farm animal pain relief and prevention solutions in the coming years.

Increase in Livestock Farming

The increase in livestock farming is a significant driver for the Global Farm Animal Pain Relief and Prevention Market. As the global demand for meat, dairy, and other animal products continues to rise, livestock farming has seen substantial growth. In 2023, the volume of chicken, pig, and cattle-the main meats produced worldwide reached 321 million tonnes. This expansion results in a greater number of animals being raised for consumption, which, in turn, leads to a higher incidence of health issues and pain-related conditions in farm animals.

Farm animals are often subjected to intensive farming practices, including castration, dehorning, and other procedures, which can cause significant pain and stress. These practices highlight the growing need for effective pain relief and prevention solutions. The rise in livestock farming also comes with an increased focus on animal welfare, with more attention being paid to the well-being of animals during their rearing and handling. Regulatory agencies and animal rights organizations are advocating for better pain management protocols, prompting farmers to adopt pain relief products to ensure compliance with ethical standards and improve the overall health of their livestock.

As livestock farming becomes more industrialized, the volume of animals requiring pain relief for medical conditions or post-surgical recovery also increases. Pain relief products, such as NSAIDs, opioids, and local anesthetics, are becoming essential tools in managing the physical health of farm animals. This growing awareness about animal pain and the importance of humane treatment drives demand for advanced pain relief solutions, benefiting the market for farm animal pain relief and prevention products. As livestock farming expands globally, the need for these solutions will continue to rise.

Key Market Challenges

High Costs of Pain Relief Products

High costs of pain relief products represent a significant challenge for the Global Farm Animal Pain Relief and Prevention Market. Many pain relief products, including NSAIDs, opioids, and anesthetics, can be expensive for farmers, particularly in regions with smaller-scale farming operations. These costs can limit the widespread adoption of effective pain management solutions, especially for livestock farmers with tight profit margins. Pain relief products often require regular and consistent administration, adding to the ongoing expenses associated with maintaining livestock health. For farmers, the high initial and ongoing costs of these treatments may deter them from purchasing the most effective or necessary products.

In addition, the financial burden is compounded by the regulatory requirements for veterinary drugs. Pain relief medications often undergo rigorous testing, approval processes, and compliance checks, all of which contribute to higher market prices. Many small and medium-sized farms may struggle to afford these products, leading to a disparity in the availability of pain relief solutions between larger commercial farms and smaller operations. This issue exacerbates the challenge of ensuring that all animals receive proper care and pain management, potentially affecting animal welfare standards.

In some regions, government subsidies or price regulations may mitigate this challenge to a degree, but this is not a universal solution. In such cases, the cost burden still remains on farmers who must decide whether to prioritize animal welfare or manage the financial pressures of running a farm. This cost-related barrier may prevent the widespread adoption of pain relief products, limiting the market's potential for growth.

Lack of Specialized Veterinary Care

One of the major challenges faced by the Global Farm Animal Pain Relief and Prevention Market is the lack of specialized veterinary care. In many regions, especially rural and remote areas, farm animals often do not receive the level of veterinary attention they require for effective pain management. A shortage of veterinarians with expertise in large animal care limits the ability to diagnose and treat pain in farm animals effectively. This is particularly evident in developing economies where veterinary professionals are scarce, and farmers may not have access to advanced pain relief treatments. Without proper pain management, animals may experience prolonged suffering, leading to decreased productivity, lower welfare standards, and even higher mortality rates.

The lack of specialized care also results in an underutilization of pain management products, as many farmers are either unaware of the available treatments or do not have the proper knowledge to administer them safely. This lack of education in pain management practices is further exacerbated by cultural and economic factors, where the priority is often placed on cost-cutting measures rather than ensuring animal welfare. In addition, the inadequate infrastructure and limited access to high-quality veterinary care also impact the market's growth potential in several regions, particularly in low-income areas where farmers rely on general veterinary services rather than specialized pain relief care.

As specialized veterinary care remains limited, efforts to expand education, resources, and services to address animal pain relief will be crucial in overcoming this challenge. The absence of dedicated professionals prevents optimal pain management strategies from being implemented, hindering the growth of the farm animal pain relief and prevention market.

Key Market Trends

Rising Demand for Natural and Organic Pain Relief Products

A significant trend influencing the Global Farm Animal Pain Relief and Prevention Market is the growing demand for natural and organic pain relief products. As consumer awareness of environmental sustainability and animal welfare increases, there is a notable shift towards organic farming practices. According to the U.S. Department of Agriculture (USDA), organic food sales in the United States surpassed USD 60 billion in 2022, marking a 31.7% increase from the previous census. This surge in organic agriculture is accompanied by a rise in certified organic farms, which increased by 5% to 17,445 between 2019 and 2021. These developments reflect a broader consumer preference for products that are both environmentally friendly and ethically produced.

In the veterinary sector, the FDA has approved several natural and organic pain relief products for animals. For instance, in January 2022, the FDA approved Solensia (frunevetmab injection), the first monoclonal antibody treatment for osteoarthritis pain in cats. Such approvals highlight the industry's commitment to providing effective, natural alternatives to traditional pain management solutions.

The increasing consumer demand for organic products, coupled with regulatory support for natural pain relief solutions, is driving the market towards more sustainable and humane practices. This trend is expected to continue, with both consumers and producers favoring natural and organic options in the farm animal pain relief and prevention market.

Expanding Use of Analgesic and Anesthetic Agents

The expanding use of analgesic and anesthetic agents is a significant trend shaping the Global Farm Animal Pain Relief and Prevention Market. As awareness about animal welfare increases, farmers and veterinarians are increasingly focusing on improving pain management practices for farm animals. This shift is driving the adoption of more sophisticated analgesic and anesthetic agents designed to provide effective pain relief during various medical procedures and after injuries or surgeries. Products like NSAIDs, opioids, local anesthetics, and alpha-2 agonists are becoming more widely used in the care of farm animals to manage both acute and chronic pain.

The growing recognition of the need to ensure proper pain management aligns with the changing regulatory landscape. Governments and animal welfare organizations have introduced policies that emphasize the humane treatment of animals, creating a demand for pain management products. For instance, anesthetic agents are frequently used in procedures such as castration, dehorning, and surgical interventions, where pain relief is essential for minimizing stress and discomfort for animals. These products not only improve the quality of life for the animals but also enhance productivity by preventing complications that could arise from untreated pain.

In addition, the increasing focus on improving animal welfare in developed economies, alongside rising awareness in developing regions, is accelerating the growth of this trend. Farmers and veterinarians are increasingly recognizing the long-term benefits of using analgesic and anesthetic agents, such as reduced stress, improved healing times, and better overall health outcomes for animals. This trend is expected to continue, with a shift toward more targeted and effective pain relief methods for farm animals, contributing to the growing market for pain relief and prevention solutions in the coming years.

Segmental Insights

Animal Type Insights

Based on the Animal Type, Cattle emerged as the dominant segment in the Global Farm Animal Pain Relief and Prevention Market in 2024. This is due to their significant role in global agriculture and the increasing focus on their welfare. Cattle are not only a primary source of milk and meat but also play a central role in the economy of many countries. As a result, there is a heightened awareness of the need to ensure their well-being, especially in relation to pain management during various medical procedures such as dehorning, castration, and calving. These practices often cause substantial pain, making the use of effective pain relief solutions critical for both animal welfare and productivity. The growing adoption of modern veterinary practices also contributes to the dominance of the cattle segment. As farmers and veterinarians become more knowledgeable about the importance of pain management, they are increasingly turning to NSAIDs, anesthetics, and other analgesic agents to mitigate discomfort and prevent long-term health complications. This focus on pain relief enhances cattle health, improves milk and meat production, and reduces the risk of infections or other health issues that could arise from untreated pain. With the increasing recognition of the economic and ethical benefits of pain relief, cattle are expected to remain the dominant segment in this market moving forward.

End User Insights

Based on the End User, Livestock Farmers emerged as the dominant segment in the Global Farm Animal Pain Relief and Prevention Market in 2024. This is due to their direct involvement in the management of animal health and well-being. As the primary stakeholders in the production of milk, meat, and other animal-based products, livestock farmers are increasingly recognizing the economic and ethical importance of managing pain in farm animals. Effective pain relief not only promotes animal welfare but also enhances the productivity and quality of the products, such as milk and meat, thereby directly benefiting the farm's bottom line. The adoption of pain relief measures by livestock farmers has been influenced by growing awareness of animal welfare regulations and the increasing pressure to ensure humane practices in animal husbandry. The use of pain management solutions such as NSAIDs, local anesthetics, and corticosteroids is crucial during common procedures such as dehorning, castration, and vaccination. Furthermore, livestock farmers are investing in advanced pain relief treatments to reduce the risk of complications, improve recovery rates, and minimize losses in production.

Regional Insights

North America emerged as the dominant region in the Global Farm Animal Pain Relief and Prevention Market in 2024. This is due to several key factors, including well-established veterinary practices, stringent animal welfare regulations, and a highly developed agricultural sector. The U.S. and Canada have large-scale farming operations where livestock production is a major industry, including cattle, poultry, and pigs. In these countries, the demand for effective pain relief and prevention solutions is high, driven by the need to enhance productivity and ensure the well-being of animals, which are critical to maintaining the quality and quantity of animal-based products. The strong regulatory framework surrounding animal welfare in North America has further spurred the adoption of pain relief solutions. These regulations require farmers to implement humane practices, including the use of analgesics and anesthetics during common procedures such as vaccinations, castrations, and surgical interventions. Additionally, the increasing awareness of the long-term benefits of pain management, such as improved recovery times and higher yields of meat and milk, has contributed to the market's growth. North America's advanced healthcare infrastructure, along with a significant investment in research and development of innovative pain relief solutions, has solidified its position as the dominant region. The availability of both over-the-counter and prescription analgesics, as well as the growing trend of precision livestock farming, further fuels market expansion in the region.

Key Market Players

• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Bayer AG
• Neogen Corporation
• Merck & Co., Inc.
• Ceva Sante Animale S.A.
• Virbac S.A.
• Vetoquinol S.A.
• Norbrook Laboratories Ltd.

Report Scope:

In this report, the Global Farm Animal Pain Relief and Prevention Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Farm Animal Pain Relief and Prevention Market, By Animal Type:

• Cattle
• Swine
• Poultry
• Equine
• Others

Farm Animal Pain Relief and Prevention Market, By Product Type:

• NSAIDs
• Opioids
• Anesthetics
• Alpha-2 Agonists
• Corticosteroids
• Local Anesthetics
• Others

Farm Animal Pain Relief and Prevention Market, By Route of Administration:

• Oral
• Injectable
• Topical
• Others

Farm Animal Pain Relief and Prevention Market, By End User:

• Livestock Farmers
• Veterinary Clinics & Hospitals
• Research Institutes
• Others

Farm Animal Pain Relief and Prevention Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Farm Animal Pain Relief and Prevention Market.

Available Customizations:

Global Farm Animal Pain Relief and Prevention Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Farm Animal Pain Relief and Prevention Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Cattle, Swine, Poultry, Equine, Others)
  • 5.2.2. By Product Type (NSAIDs, Opioids, Anesthetics, Alpha-2 Agonists, Corticosteroids, Local Anesthetics, Others)
  • 5.2.3. By Route of Administration (Oral, Injectable, Topical, Others)
  • 5.2.4. By End User (Livestock Farmers, Veterinary Clinics & Hospitals, Research Institutes, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Farm Animal Pain Relief and Prevention Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product Type
  • 6.2.3. By Route of Administration
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Farm Animal Pain Relief and Prevention Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Farm Animal Pain Relief and Prevention Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Farm Animal Pain Relief and Prevention Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By End User

7. Europe Farm Animal Pain Relief and Prevention Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product Type
  • 7.2.3. By Route of Administration
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Route of Administration
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Farm Animal Pain Relief and Prevention Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Route of Administration
      • 7.3.5.2.4. By End User

8. Asia-Pacific Farm Animal Pain Relief and Prevention Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product Type
  • 8.2.3. By Route of Administration
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By End User
  • 8.3.2. India Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Route of Administration
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Farm Animal Pain Relief and Prevention Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Route of Administration
      • 8.3.5.2.4. By End User

9. South America Farm Animal Pain Relief and Prevention Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product Type
  • 9.2.3. By Route of Administration
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Farm Animal Pain Relief and Prevention Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Farm Animal Pain Relief and Prevention Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Farm Animal Pain Relief and Prevention Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By End User

10. Middle East and Africa Farm Animal Pain Relief and Prevention Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product Type
  • 10.2.3. By Route of Administration
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Farm Animal Pain Relief and Prevention Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Route of Administration
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Farm Animal Pain Relief and Prevention Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Route of Administration
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Farm Animal Pain Relief and Prevention Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Route of Administration
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Zoetis Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Boehringer Ingelheim International GmbH
• 14.3. Elanco Animal Health Incorporated
• 14.4. Bayer AG
• 14.5. Neogen Corporation
• 14.6. Merck & Co., Inc.
• 14.7. Ceva Sante Animale S.A.
• 14.8. Virbac S.A.
• 14.9. Vetoquinol S.A.
• 14.10. Norbrook Laboratories Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer